Form 8-K - Current report:
SEC Accession No. 0000950170-24-138478
Filing Date
2024-12-19
Accepted
2024-12-19 16:27:44
Documents
11
Period of Report
2024-12-19
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K alks-20241219.htm   iXBRL 8-K 49686
  Complete submission text file 0000950170-24-138478.txt   170850

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alks-20241219.xsd EX-101.SCH 30800
14 EXTRACTED XBRL INSTANCE DOCUMENT alks-20241219_htm.xml XML 4683
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 241563696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)